Latest news
OKYO Pharma (NASDAQ: OKYO) updates 20-F to add clawback policy exhibit - Stock TitanStock Titan · Fri, 07 Aug 2026 20:31:16 GMTOKYO Pharma (OKYO) director buys 5,000 shares in open market - Stock TitanStock Titan · Fri, 07 Aug 2026 20:16:29 GMTOKYO Pharma scientist's holdings reach 20,030 shares after purchase - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTOKYO Pharma (Nasdaq: OKYO) CSO boosts stake, plans Phase 3 NCP trial - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTOKYO Pharma plans 111-patient Phase 3 corneal pain trial - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMTOKYO Pharma (Nasdaq: OKYO) plans Phase 3 NCP trial, joins BTIG conference - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT